Ernexa Therapeutics, Inc. (ERNA)
6.04
+2.05
(+51.38%)
USD |
NASDAQ |
May 06, 16:00
6.72
+0.68
(+11.26%)
Pre-Market: 08:26
Ernexa Therapeutics Free Cash Flow : -7.054M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Ocular Therapeutix, Inc. | -240.94M |
| Quince Therapeutics, Inc. | -41.78M |
| Recursion Pharmaceuticals, Inc. | -328.08M |
| Tango Therapeutics, Inc. | -139.93M |
| Aprea Therapeutics, Inc. | -13.44M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -1.148M |
| Cash from Investing (Quarterly) | -0.015M |
| Free Cash Flow Per Share (Quarterly) | -3.702 |
| Free Cash Flow to Equity (Quarterly) | -1.101M |
| Free Cash Flow to Firm (Quarterly) | -1.163M |
| Free Cash Flow Yield | -8.62% |